To alleviate its financial issues and strengthen its arks, FC Barcelona is continuing its quest for new sources of income by conducting research.
Among the most important conversations is the possibility of renewing the agreement with Nike, a brand that has been with them since 1998 and has the potential to make a big contribution to this cause. Even though both parties expressed a lack of interest in the matter, the agreement is getting closer to operational, as per FCBN.
Barcelona Finalizes Long-Term Deal with Nike After Legal Ruling Blocks Other Options
After examining alternatives with Cougar, who provided a very tempting offer, and even considering the idea of launching his own mark, the Barcelona team was forced to come to terms with the North American mark. The club reported the legal agreement until 2028, supported by a court ruling that it could not sign with another mark nor produce its own apparel. This resulted in this situation.
However, Nike approached him even more rather than distancing themselves from him and turning him away from the Barcelona club. The American brand understood that the Barcelona club required a more favorable agreement because of its position. Considering this, they have proposed a ten-year contract that includes a hefty incentive upon renewal (estimated to be around 150 million euros) and an annual fixed payment that has the potential to exceed 100 kilos.
Nike Nears Agreement with City Council, Final Details Pending Resolution
Even if there are still some minor elements that need to be resolved, the agreement appears to be on the verge of being reached, as they have been informed by the City Council.
Nike is getting closer and closer to reaching a deal compared to the previous weeks. Immediately following the conclusion of the Champions feminine competition in Saint Mamés, Nicholas Barthes, the vice president of Nike in Europe, engaged in a conversation with Joan Laporta, thereby strengthening his relationship with her.
On the other hand, the same club sources guarantee that the agreement will not be closed for the upcoming board meeting this Thursday.


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Why the Australian Open’s online tennis coverage looks like a Wii sports game
Native American Groups Slam Trump’s Call to Restore Redskins Name
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
LA28 Confirms Olympic Athletes Exempt from Trump’s Travel Ban
FDA Approves Mitapivat for Anemia in Thalassemia Patients
From Messi to Mika Häkkinen: how top athletes can slow down time
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Trump Plans UFC Event at White House for America’s 250th Anniversary
Trump Attends Super Bowl Amid Cheers, Boos, and Political Divide
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 



